Confluence Wealth Services’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$814K Buy
+4,292
New +$807K 0.02% 263
2026
Q1
Sell
-3,991
Closed -$734K 368
2025
Q4
$734K Sell
3,991
-1,883
-32% -$330K 0.03% 220
2025
Q3
$901K Sell
5,874
-48
-0.8% -$7.26K 0.04% 188
2025
Q2
$828K Sell
5,922
-60
-1% -$8.41K 0.05% 190
2025
Q1
$820K Hold
5,982
0.05% 177
2024
Q4
$821K Sell
5,982
-15
-0.3% -$2.1K 0.05% 172
2024
Q3
$934K Sell
5,997
-37
-0.6% -$5.97K 0.07% 152
2024
Q2
$941K Sell
6,034
-456
-7% -$68.6K 0.08% 160
2024
Q1
$879K Sell
6,490
-150
-2% -$19.9K 0.08% 143
2023
Q4
$894K Sell
6,640
-371
-5% -$48.2K 0.1% 124
2023
Q3
$949K Buy
7,011
+257
+4% +$35.1K 0.19% 91
2023
Q2
$967K Hold
6,754
0.2% 95
2023
Q1
$938K Buy
6,754
+24
+0.4% +$3.23K 0.22% 90
2022
Q4
$913K Hold
6,730
0.24% 90
2022
Q3
$738K Sell
6,730
-357
-5% -$45.3K 0.31% 88
2022
Q2
$916K Buy
7,087
+37
+0.5% +$4.86K 0.4% 83
2022
Q1
$935K Buy
+7,050
New +$845K 0.34% 84

Other funds holding AZN

Confluence Wealth Services's AZN Position: Q2 2026 in Review

Confluence Wealth Services opened a new position in AstraZeneca (AZN) in Q2 2026: 4,292 shares worth $814K. The stake represents 0.02% of the portfolio and ranks #263 among its holdings. This is a return to the name: Confluence Wealth Services previously reported a position in AZN as recently as Q4 2025.

Confluence Wealth Services first reported a position in AZN in Q1 2022 and has held it in 17 quarters since. The position peaked at $967K in Q2 2023. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Confluence Wealth Services held 4,292 shares of AstraZeneca worth $814K as of Q2 2026.
  • AstraZeneca was a new Confluence Wealth Services position in Q2 2026.
  • AstraZeneca made up 0.02% of Confluence Wealth Services's portfolio in Q2 2026, its #263 holding.
  • Confluence Wealth Services first reported a position in AstraZeneca in Q1 2022 and has held it in 17 quarters since.
  • Confluence Wealth Services's AstraZeneca position peaked at $967K in Q2 2023.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Confluence Wealth Services's 13F filing for Q2 2026, filed 22 Jul 2026.